Results 151 to 160 of about 1,107,385 (201)

Clinical assessment of mocravimod as a victim of drug-drug interactions via CYP3A4 metabolism and transporters. [PDF]

Clin Pharmacol Drug Dev
Huntjens DR, Oehen S, Kueenburg E.
europepmc   +1 more source

Drug-drug interactions: A descriptive analysis of FDA adverse event reporting system. [PDF]

Medicine (Baltimore)
Alahmari A, Fatani S, Ahmed N.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Identification of Serious Drug–Drug Interactions: Results of the Partnership to Prevent Drug–Drug Interactions

Journal of the American Pharmacists Association: JAPhA, 2004
To develop a list of clinically important drug-drug interactions (DDIs) likely to be encountered in community and ambulatory pharmacy settings and detected by a computerized pharmacy system.Cross-sectional, one-time evaluation.United States in fall 2001.An expert panel comprising two physicians, two clinical pharmacists, and an expert on DDIs ...
Daniel C Malone, Edward P Armstrong, Jacob Abarca   +2 more
exaly   +3 more sources

Drug–drug interactions

2018
A drug interaction occurs when the effects of a drug are altered by the effects of another drug, a vaccine, herb, foodstuff, or device. In drug–drug interactions, a precipitant drug increases or reduces the effects of an object drug by pharmaceutical, pharmacokinetic, or pharmacodynamic mechanisms.
Lopamudra Chowdhury, Om Singh
  +6 more sources

Drug–drug interaction with statins

Expert Review of Clinical Pharmacology, 2008
3-hydroxy-3-methyl-glutaryl (HMG)-CoA reductase inhibitors (the so-called statins: atorvastatin, fluvastatin, pravastatin, lovastatin, rosuvastatin and simvastatin) are a well-established class of drugs in the treatment of hypercholesterolemia. Statin monotherapy is generally well tolerated, with a low frequency of adverse events.
A. Corsini, S. Bellosta
openaire   +2 more sources